A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients
Clinical trial NCT00787891 · COMPLETED
Trial details
- NCT number
- NCT00787891
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-01-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.